Global Varicella Attenuated Live Vaccine Market Study 2015-2025, by Segment (Monovalent Vaccine, Combination Vaccine), by Market (Kids Injection, Adults InjectionCombination Vaccine), by Company (Merck, GSK, Shanghai Institute)

October 2018 | 61 pages | ID: G7ECA289B46EN
99Strategy

Abstracts

Snapshot

A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.

The global Varicella Attenuated Live Vaccine market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Monovalent Vaccine
• Combination Vaccine

Demand Coverage (Market Size & Forecast, Consumer Distribution):

• Kids Injection
• Adults Injection

Company Coverage (Sales data, Main Products & Services etc.):

• Merck
• GSK
• Shanghai Institute
• BCHT
• Changsheng
• Keygen
• Green Cross
• Biken

Major Region Market

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Contents

1 INDUSTRY OVERVIEW

1.1 Varicella Attenuated Live Vaccine Industry
  1.1.1 Overview
  1.1.2 Products of Major Companies
1.2 Market Segment
  1.2.1 Industry Chain
  1.2.2 Consumer Distribution
1.3 Price & Cost Overview

2 VARICELLA ATTENUATED LIVE VACCINE MARKET BY TYPE

2.1 By Type
  2.1.1 Monovalent Vaccine
  2.1.2 Combination Vaccine
2.2 Market Size by Type
2.3 Market Forecast by Type

3 GLOBAL MARKET DEMAND

3.1 Segment Overview
  3.1.1 Kids Injection
  3.1.2 Adults Injection
3.2 Market Size by Demand
3.3 Market Forecast by Demand

4 MAJOR REGION MARKET

4.1 Global Market Overview
  4.1.1 Market Size & Growth
  4.1.2 Market Forecast
4.2 Major Region
  4.2.1 Market Size & Growth
  4.2.2 Market Forecast

5 MAJOR COMPANIES LIST

5.1 Merck (Company Profile, Sales Data etc.)
5.2 GSK (Company Profile, Sales Data etc.)
5.3 Shanghai Institute (Company Profile, Sales Data etc.)
5.4 BCHT (Company Profile, Sales Data etc.)
5.5 Changsheng (Company Profile, Sales Data etc.)
5.6 Keygen (Company Profile, Sales Data etc.)
5.7 Green Cross (Company Profile, Sales Data etc.)
5.8 Biken (Company Profile, Sales Data etc.)

6 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Varicella Attenuated Live Vaccine Market 2015-2018, by Type, in USD Million
Table Global Varicella Attenuated Live Vaccine Market 2015-2018, by Type, in Volume
Table Global Varicella Attenuated Live Vaccine Market Forecast 2019-2025, by Type, in USD Million
Table Global Varicella Attenuated Live Vaccine Market Forecast 2019-2025, by Type, in Volume
Table Merck Overview List
Table Varicella Attenuated Live Vaccine Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Varicella Attenuated Live Vaccine Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Shanghai Institute Overview List
Table Varicella Attenuated Live Vaccine Business Operation of Shanghai Institute (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BCHT Overview List
Table Varicella Attenuated Live Vaccine Business Operation of BCHT (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Changsheng Overview List
Table Varicella Attenuated Live Vaccine Business Operation of Changsheng (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Keygen Overview List
Table Varicella Attenuated Live Vaccine Business Operation of Keygen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Green Cross Overview List
Table Varicella Attenuated Live Vaccine Business Operation of Green Cross (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biken Overview List
Table Varicella Attenuated Live Vaccine Business Operation of Biken (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

List Of Figures

LIST OF FIGURES

Figure Global Varicella Attenuated Live Vaccine Market Growth 2015-2018, by Type, in USD Million
Figure Global Varicella Attenuated Live Vaccine Market Growth 2015-2018, by Type, in Volume